iSensIRs Draws Over 250 Participants for Breath Gas Analysis at 'COMEUP 2025'
Over 250 people joined the breath gas demo across three days… "Industry insiders praise the real-time analysis technology"
iSensIRs, Inc. successfully concluded its participation in 'ComeUp 2025,' the global startup festival held from December 10 to 12.
At this exhibition, iSensIRs showcased its independently developed 'ultra-sensitive breath gas analyzer' and 'real-time monitoring system for industrial/environmental emission gases,'
drawing keen interest from healthcare and bio industry insiders.
■ 'Real-time analysis technology' proven by the breath of 250 people
The on-site demonstration drew the most attention. During the exhibition, approximately 400 visitors came to the booth, and over 250 of them experienced breath gas analysis firsthand. Participants were amazed by the technology that, without any separate blood draw or pain and simply by breathing comfortably, checks in real time the concentration of toluene gas—actively studied in relation to lung cancer, among the gas molecules being very actively researched as disease-related biomarkers for lung cancer, colorectal cancer, breast cancer, kidney disease, and more.
■ Successive interest from leading healthcare companies
Beyond simple demonstrations, discussions on business collaboration were also active. Representatives from major companies and investors leading the domestic and international healthcare appliance market visited the booth and expressed interest. This is expected to serve as a positive signal for future strategic partnerships and technology alliances.
ComeUp 2025 was an occasion that confirmed our technology can fully resonate beyond the lab with the public and the market. Living up to the expectations shown on-site, we will accelerate the era in which anyone can protect their health with a single breath.
Thank you to everyone who supported us.
